12.10.2017 13:10:37

Fate Therapeutics Buy

Der Analyst H.C. Wainwright & Co. hat Fate Therapeutics Inc wieder aufgenommen mit der Einstufung "Buy" und einem Kursziel von 7 USD.
Zusammenfassung: Fate Therapeutics Inc Buy
Unternehmen:
Fate Therapeutics Inc
Analyst:
H.C. Wainwright & Co.
Kursziel:
$ 7.00
Rating jetzt:
Buy
Kurs*:
3.44 €
Abst. Kursziel*:
103.19%
Rating update:
resumed
Kurs aktuell:
$ 11.37
Abst. Kursziel aktuell:
-38.43%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Analysen zu Fate Therapeutics Incmehr Analysen

06.03.18 Fate Therapeutics Neutral H.C. Wainwright & Co.
12.10.17 Fate Therapeutics Buy H.C. Wainwright & Co.
08.11.16 Fate Therapeutics Outperform Wedbush Morgan Securities Inc.

Eintrag hinzufügen

Aktien in diesem Artikel

Fate Therapeutics Inc 11.37 0.26% Fate Therapeutics Inc

Aktuelle Aktienanalysen

18:24 Cantor Fitzgerald
GW Pharmaceuticals Overweight
17:32 The Benchmark Company
Tyler Technologies Buy
17:19 JP Morgan Chase & Co.
Nestlé overweight
17:05 Aegis Capital
eBay Buy
16:30 S&P Capital IQ
Schneider Electric Hold
16:00 Goldman Sachs Group Inc.
Amazon Conviction Buy List
15:23 Oppenheimer & Co. Inc.
8X8 Outperform
15:06 Deutsche Bank AG
SAP buy
14:58 Morgan Stanley
Amazon kaufen
14:56 Lake Street
Sientra Hold
14:52 Barclays Capital
Intel overweight
14:52 Needham & Company, LLC
ADTRAN Buy
14:51 UBS AG
Nestlé Neutral
14:45 UBS AG
Unilever buy
14:31 Stifel, Nicolaus & Co., Inc.
Badger Meter Hold
14:24 Cowen and Company, LLC
Alcoa Market Perform
14:03 Maxim Group
Dynagas LNG Partners LP Partnership Units Buy
13:43 B. Riley FBR, Inc.
Southern Copper Neutral
13:40 JP Morgan Chase & Co.
Schneider Electric kaufen
13:26 Morgan Stanley
BMW Underweight
13:23 UBS AG
Schneider Electric Neutral
13:20 UBS AG
Rio Tinto buy
13:14 Imperial Capital
United Continental In-line
13:13 Imperial Capital
Travelport Worldwide Outperform
13:12 Imperial Capital
Sabre Outperform
13:05 Kepler Cheuvreux
zooplus Reduce
13:03 Kepler Cheuvreux
Merck buy
13:03 Kepler Cheuvreux
Continental buy
13:00 UBS AG
Novartis Neutral
12:59 UBS AG
ABB Neutral
12:50 Norddeutsche Landesbank (Nord/LB)
Continental Halten
12:46 Commerzbank AG
Aurubis (ex Norddeutsche Affinerie) Reduce
12:46 Commerzbank AG
Continental Hold
12:45 Commerzbank AG
GEA Reduce
12:41 Commerzbank AG
Merck Hold
12:40 UBS AG
Enel buy
12:36 Commerzbank AG
zooplus neutral
12:35 Goldman Sachs Group Inc.
Swiss Re Neutral
12:35 Warburg Research
Continental buy
12:31 Warburg Research
TAKKT buy
12:30 Warburg Research
STRATEC Biomedical Hold
11:53 Credit Suisse Group
HSBC Neutral
11:20 Commerzbank AG
zooplus Hold
11:13 RBC Capital Markets
National Grid neutral
11:12 Warburg Research
zooplus Hold
11:11 Warburg Research
Hapag-Lloyd Hold
11:08 Credit Suisse Group
ASML NV Outperform
10:43 UBS AG
ASML NV buy
10:40 UBS AG
Vodafone Group buy
10:40 UBS AG
adidas buy